chr1-197143319-G-C
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The ENST00000367409.9(ASPM):āc.933C>Gā(p.Ser311Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000418 in 1,613,804 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S311T) has been classified as Likely benign.
Frequency
Consequence
ENST00000367409.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASPM | NM_018136.5 | c.933C>G | p.Ser311Arg | missense_variant | 3/28 | ENST00000367409.9 | NP_060606.3 | |
ASPM | NM_001206846.2 | c.933C>G | p.Ser311Arg | missense_variant | 3/27 | NP_001193775.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASPM | ENST00000367409.9 | c.933C>G | p.Ser311Arg | missense_variant | 3/28 | 1 | NM_018136.5 | ENSP00000356379 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152100Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000741 AC: 186AN: 250976Hom.: 2 AF XY: 0.00103 AC XY: 140AN XY: 135768
GnomAD4 exome AF: 0.000436 AC: 637AN: 1461586Hom.: 12 Cov.: 33 AF XY: 0.000612 AC XY: 445AN XY: 727106
GnomAD4 genome AF: 0.000250 AC: 38AN: 152218Hom.: 0 Cov.: 33 AF XY: 0.000363 AC XY: 27AN XY: 74442
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:3
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 29, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | ASPM: BP4 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Apr 10, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 05, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 18, 2023 | - - |
Microcephaly 5, primary, autosomal recessive Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Aug 07, 2018 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jun 05, 2015 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at